APA

Liang J., Wang L., Zhu H., Qian J., Liao H., Wu J., Xia Y., Wu W., Cao L., Fan L., Li J. & Xu W. (20210427). Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. : Haematologica.

Chicago

Liang Jin-Hua, Wang Li, Zhu Hua-Yuan, Qian Jun, Liao Hui, Wu Jia-Zhu, Xia Yi, Wu Wei, Cao Lei, Fan Lei, Li Jian-Yong and Xu Wei. 20210427. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. : Haematologica.

Harvard

Liang J., Wang L., Zhu H., Qian J., Liao H., Wu J., Xia Y., Wu W., Cao L., Fan L., Li J. and Xu W. (20210427). Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. : Haematologica.

MLA

Liang Jin-Hua, Wang Li, Zhu Hua-Yuan, Qian Jun, Liao Hui, Wu Jia-Zhu, Xia Yi, Wu Wei, Cao Lei, Fan Lei, Li Jian-Yong and Xu Wei. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. : Haematologica. 20210427.